Literature DB >> 172955

Newer angiographic observations in cholangiocarcinoma.

J F Walter, J J Bookstein, E V Bouffard.   

Abstract

Three new angiographic features of cholangiocarcinoma are bile duct dilatation, venous obstruction and arterio-arterial collaterals. Differentiation of the lucencies of dilated bile ducts (cylindrical in shape) from those due to metastases (spherical) is discussed. Because of its high reliability and the difficulties of operative diagnosis, angiography can play an important diagnostic role in patients with suspected cholangiocarcinoma.

Entities:  

Mesh:

Year:  1976        PMID: 172955     DOI: 10.1148/118.1.19

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  5 in total

1.  Angiographic and pathologic features of probable primary carcinoid-like hepatic tumors.

Authors:  J F Walter; H D Appelman; S R Reuter
Journal:  Gastrointest Radiol       Date:  1978-10-01

2.  Primary adenocarcinoma of the bile ducts. Clinical characteristics and natural history.

Authors:  J T Bruggen; M S McPhee; P S Bhatia; J M Richter
Journal:  Dig Dis Sci       Date:  1986-08       Impact factor: 3.199

3.  Radiologically identifiable intratumoral portal vein in intrahepatic cholangiomas: a diagnostic pitfall.

Authors:  K Kaneko; H Honda; K Kajiyama; Y Yokomizo; N Hashiguchi; T Fukuya; Y Tateshi; T Ro; K Masuda
Journal:  Abdom Imaging       Date:  1996 Sep-Oct

4.  Cholangiocarcinoma. Role of percutaneous transhepatic cholangiography in determination of resectability.

Authors:  R B Lynn; J A Wilson; K J Cho
Journal:  Dig Dis Sci       Date:  1988-05       Impact factor: 3.199

Review 5.  Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma.

Authors:  Pavan Najran; Angela Lamarca; Damian Mullan; Mairéad G McNamara; Thomas Westwood; Richard A Hubner; Jeremy Lawrence; Prakash Manoharan; Jon Bell; Juan W Valle
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.